ACAD EPS Estimates - ACADIA Pharmaceuticals Inc. logo

ACAD EPS Estimates

ACADIA Pharmaceuticals Inc.

$17.66
-$0.17(-0.98%)
50
Overall
75
Value
18
Tech
57
Quality
How is this score calculated?
Market Cap
$3.05B
Volume
861.71K
52W Range
$15.86 - $30.96
Target Price
$30.05

ACAD EPS estimates: the consensus estimate for ACADIA Pharmaceuticals Inc.'s current fiscal year is $0.76 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

ACAD EPS Estimates

EPS estimate, current quarter
$0.28
EPS estimate, next quarter
$0.20
EPS estimate, current year
$0.76
EPS estimate, next year
$1.08
EPS growth, 3-year
+0.00%
ACAD reported EPS by year
Fiscal yearEPS
2012$-0.38
2011$-0.44
ABCD
1SymbolPriceChangeVol
2ACAD$17.66-1.0%861.71K
3
4
5
6

Get ACADIA Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.